GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (BOM:524669) » Definitions » Cyclically Adjusted PB Ratio

Hester Biosciences (BOM:524669) Cyclically Adjusted PB Ratio : 6.74 (As of Jul. 02, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Hester Biosciences Cyclically Adjusted PB Ratio?

As of today (2025-07-02), Hester Biosciences's current share price is ₹1813.35. Hester Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹269.16. Hester Biosciences's Cyclically Adjusted PB Ratio for today is 6.74.

The historical rank and industry rank for Hester Biosciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:524669' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.06   Med: 7.98   Max: 10.5
Current: 6.86

During the past years, Hester Biosciences's highest Cyclically Adjusted PB Ratio was 10.50. The lowest was 6.06. And the median was 7.98.

BOM:524669's Cyclically Adjusted PB Ratio is ranked worse than
88.87% of 746 companies
in the Drug Manufacturers industry
Industry Median: 1.99 vs BOM:524669: 6.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hester Biosciences's adjusted book value per share data for the three months ended in Mar. 2025 was ₹369.408. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹269.16 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hester Biosciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hester Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hester Biosciences Cyclically Adjusted PB Ratio Chart

Hester Biosciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.66

Hester Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 9.65 - 4.66

Competitive Comparison of Hester Biosciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hester Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hester Biosciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hester Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hester Biosciences's Cyclically Adjusted PB Ratio falls into.


;
;

Hester Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hester Biosciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1813.35/269.16
=6.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hester Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Hester Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=369.408/157.5517*157.5517
=369.408

Current CPI (Mar. 2025) = 157.5517.

Hester Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201003 52.477 65.030 127.138
201103 0.000 70.768 0.000
201203 70.248 76.889 143.944
201206 0.000 79.567 0.000
201209 151.637 82.244 290.485
201212 0.000 83.774 0.000
201303 79.110 85.687 145.459
201403 88.176 91.425 151.953
201503 99.825 97.163 161.868
201603 120.881 102.518 185.772
201703 143.348 105.196 214.692
201803 165.316 109.786 237.241
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 208.603 118.202 278.047
201906 0.000 120.880 0.000
201909 217.004 123.175 277.567
201912 0.000 126.235 0.000
202003 236.362 124.705 298.618
202006 0.000 127.000 0.000
202009 245.066 130.118 296.735
202012 0.000 130.889 0.000
202103 268.377 131.771 320.886
202106 0.000 134.084 0.000
202109 286.398 135.847 332.157
202112 0.000 138.161 0.000
202203 305.613 138.822 346.846
202206 0.000 142.347 0.000
202209 310.431 144.661 338.093
202212 0.000 145.763 0.000
202303 328.823 146.865 352.751
202306 0.000 150.280 0.000
202309 331.404 151.492 344.660
202312 0.000 152.924 0.000
202403 343.003 153.035 353.128
202406 0.000 155.789 0.000
202409 354.802 157.882 354.059
202412 0.000 158.323 0.000
202503 369.408 157.552 369.408

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hester Biosciences  (BOM:524669) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hester Biosciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hester Biosciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hester Biosciences Business Description

Traded in Other Exchanges
Address
Motilal Hirabhai Road, Pushpak, 1st Floor, Panchvati Circle, Ahmedabad, GJ, IND, 380006
Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.

Hester Biosciences Headlines

No Headlines